An increase suggests active cost-cutting or structural transformation, while a decrease indicates the completion of restructuring phases.
Represents the cash outflows associated with organizational restructuring initiatives, such as severance packages, facil...
Commonly reported by utilities and large industrial firms undergoing strategic shifts or cost-optimization programs.
cvx_payments_for_restructuring| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | Q4 '26 |
|---|---|---|---|---|---|---|---|---|
| Medical-Surgical Solutions | $4.00M | $3.00M | $44.00M | $48.00M | $50.00M | $37.00M | $43.00M | $3.00M |
| North American Pharmaceutical | — | — | — | — | — | — | — | $1.00M |
| International | $1.00M | $1.00M | — | — | $0.00 | — | — | — |
| Prescription Technology Solutions | $1.00M | $1.00M | $2.00M | — | $0.00 | $1.00M | — | — |
| U.S. Pharmaceutical | $3.00M | $1.00M | $0.00 | $4.00M | $2.00M | — | — | — |
| Total | — | — | — | — | — | — | — | — |
Oncology & Multispecialty is derived from annual filings.
International, U.S. Pharmaceutical were previously reported and have since been discontinued or reclassified. Only currently active segments are shown in the chart.